Shares of Cardlytics, Inc. (NASDAQ:CDLX – Get Free Report) have earned an average rating of “Hold” from the seven ratings firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $6.42.
Several brokerages recently issued reports on CDLX. Needham & Company LLC restated a “hold” rating on shares of Cardlytics in a report on Thursday, March 13th. Lake Street Capital decreased their price objective on Cardlytics from $5.00 to $3.00 and set a “hold” rating for the company in a research note on Thursday, March 13th. Finally, Evercore ISI lowered their target price on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research note on Thursday, March 13th.
Check Out Our Latest Stock Analysis on CDLX
Insider Activity
Institutional Investors Weigh In On Cardlytics
A number of hedge funds and other institutional investors have recently modified their holdings of CDLX. Mirabella Financial Services LLP purchased a new position in shares of Cardlytics during the 4th quarter worth approximately $4,285,000. D. E. Shaw & Co. Inc. lifted its holdings in shares of Cardlytics by 97.4% during the 4th quarter. D. E. Shaw & Co. Inc. now owns 1,131,505 shares of the company’s stock worth $4,198,000 after acquiring an additional 558,235 shares during the period. Rangeley Capital LLC purchased a new position in Cardlytics during the fourth quarter worth approximately $1,187,000. RBF Capital LLC boosted its holdings in Cardlytics by 64.7% in the fourth quarter. RBF Capital LLC now owns 803,763 shares of the company’s stock valued at $2,982,000 after acquiring an additional 315,635 shares during the last quarter. Finally, Millennium Management LLC acquired a new position in shares of Cardlytics in the 4th quarter valued at about $535,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.
Cardlytics Price Performance
NASDAQ:CDLX opened at $1.41 on Tuesday. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a market cap of $73.44 million, a PE ratio of -0.23 and a beta of 1.39. The stock has a 50 day moving average price of $2.33 and a 200 day moving average price of $3.21. Cardlytics has a one year low of $1.22 and a one year high of $15.89.
Cardlytics Company Profile
Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.
Recommended Stories
- Five stocks we like better than Cardlytics
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Why NVIDIA Stock Could Soar Despite Wall Street Downgrades
- Canada Bond Market Holiday: How to Invest and Trade
- Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or Hold
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Hot New IPOs Defying the 2025 Market Slump
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.